PAX8 and cyclic hematopoiesis: Together with the other two novel PAX8 mutations, G41V and R31H, which we had identified in a portion of this cohort of CH [25], the overall prevalence of PAX8 mutations in the Chinese patients with TD/CH is 1.1% (5/453).